Xiaoming Jia Selected Research

Xiaoming Jia Research Topics

Disease

19	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2018
14	Heart Failure 11/2023 - 01/2019
8	Atherosclerosis 11/2023 - 11/2018
7	Stroke (Strokes) 12/2023 - 01/2018
5	Inflammation (Inflammations) 03/2024 - 01/2016
5	Multiple Sclerosis 03/2024 - 01/2022
5	Coronary Disease (Coronary Heart Disease) 11/2023 - 01/2020
4	Atrial Fibrillation 11/2023 - 01/2018
3	Hypertension (High Blood Pressure) 12/2023 - 01/2020
2	Myocardial Infarction 02/2024 - 12/2023
2	Thrombosis (Thrombus) 02/2024 - 01/2021
2	Acute Coronary Syndrome 12/2023 - 11/2019
2	Ischemic Stroke 11/2023 - 11/2022
2	Disease Progression 07/2023 - 01/2022
2	COVID-19 05/2021 - 10/2020
2	Infections 05/2021 - 10/2020
2	Hemorrhage 01/2020 - 11/2019
2	Weight Loss (Weight Reduction) 11/2019 - 01/2018
2	Rheumatoid Arthritis 07/2013 - 01/2012
2	Wounds and Injuries (Trauma) 12/2012 - 11/2012
2	Contracture 12/2012 - 11/2012
1	ST Elevation Myocardial Infarction 02/2024
1	Acute Disease 07/2023
1	Chronic Progressive Multiple Sclerosis 07/2023
1	Hypertriglyceridemia 05/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	Atrophy 01/2022
1	Fibrosis (Cirrhosis) 11/2021
1	Hypercholesterolemia 11/2020
1	Xanthomatosis (Xanthoma) 11/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020
1	Chronic Renal Insufficiency 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Dementia (Dementias) 01/2020
1	Genetic Risk Score 01/2020
1	Thoracic Aorta Dissection 01/2020
1	Homozygous Familial Hypercholesterolemia 01/2020
1	Frailty 01/2020
1	Obesity 11/2019
1	Diabetes Mellitus 11/2019

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2021
6	LipidsIBA 05/2023 - 01/2019
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2022 - 01/2019
4	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023 - 01/2021
4	Troponin IIBA 12/2023 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 07/2023 - 12/2010
4	oxidized low density lipoproteinIBA 11/2022 - 01/2019
4	LDL CholesterolIBA 12/2021 - 01/2019
4	Amino Acids FDA Link 07/2013 - 12/2010
3	ocrelizumabIBA 07/2023 - 01/2022
2	TroponinIBA 12/2023 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 11/2022
2	Antihypertensive Agents (Antihypertensives)IBA 11/2022 - 10/2020
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 01/2020
2	eicosapentaenoic acid ethyl esterIBA 10/2020 - 01/2020
2	alirocumabIBA 01/2020 - 11/2019
2	HLA-DQB1 antigen (HLA DQB1)IBA 01/2016 - 01/2012
2	HLA-DRB1 Chains (HLA DRB1)IBA 07/2013 - 01/2012
2	Peptides (Polypeptides)IBA 01/2012 - 12/2010
2	HLA-B Antigens (HLA-B)IBA 01/2012 - 03/2011
2	HLA-A Antigens (HLA-A)IBA 01/2012 - 03/2011
1	omega-Chloroacetophenone (Mace)IBA 02/2024
1	Troponin T (Troponin T1)IBA 12/2023
1	Interleukin-18 (Interleukin 18)IBA 11/2023
1	Interleukin-6 (Interleukin 6)IBA 11/2023
1	CytokinesIBA 11/2023
1	lipoprotein cholesterolIBA 01/2023
1	pro-brain natriuretic peptide (1-76)IBA 01/2023
1	Lipoproteins (Lipoprotein)IBA 11/2022
1	Apolipoprotein C-IIIIBA 11/2022
1	Angiopoietin-Like Protein 3IBA 11/2022
1	Proprotein Convertase 9IBA 01/2022
1	PCSK9 InhibitorsIBA 01/2022
1	Galectin 3 (LGALS3)IBA 11/2021
1	LectinsIBA 11/2021
1	Vitamin K FDA Link 01/2021
1	AnticoagulantsIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Dehydroepiandrosterone (DHEA)IBA 12/2020
1	Dehydroepiandrosterone SulfateIBA 12/2020
1	Lipoprotein-XIBA 11/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020
1	vupanorsenIBA 10/2020
1	Colchicine FDA LinkGeneric 10/2020
1	empagliflozinIBA 10/2020
1	Angiotensin Receptor AntagonistsIBA 10/2020
1	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2020
1	evinacumabIBA 01/2020
1	vericiguatIBA 01/2020
1	Angiopoietin-Like Protein 8IBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2019

Therapy/Procedure

14	Therapeutics 07/2023 - 12/2017
2	Glycemic Control 11/2019 - 01/2018
1	Percutaneous Coronary Intervention 02/2024
1	Stents 02/2024
1	Plasmapheresis 11/2020
1	Braces 10/2020
1	Denervation 01/2020
1	Secondary Prevention 11/2019